1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Israel >
  5. Candela Acquires Fluorinex Active

M&A Deal Summary

Candela Acquires Fluorinex Active

On April 12, 2007, Candela acquired medical products company Fluorinex Active

Acquisition Highlights
  • This is Candela’s 1st transaction in the Medical Products sector.
  • This is Candela’s 1st transaction in Israel.

M&A Deal Summary
Date 2007-04-12
Target Fluorinex Active
Sector Medical Products
Buyer(s) Candela
Deal Type Add-on Acquisition

Target

Fluorinex Active

Yokneam, Israel
Fluorinex Active Ltd. is an Israeli-based start-up to develop advanced fluoridation and tooth whitening devices for dentists and consumers. Fluorinex has developed a unique device that delivers fluoride ions directly to the tooth enamel via a sophisticated electro-chemical technique. The Fluorinex technology delivers the maximum amount of fluoride ions to the tooth, for the longest endurance of time known today.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Candela

Marlborough, Massachusetts, United States
Category Company
Founded 1970
Sector Medical Products
Revenue 278M USD (2015)
DESCRIPTION

Candela is a US-based global medical aesthetic device company. The company's technologies enable physicians to provide advanced energy-based solutions for a broad range of medical-aesthetic applications including benign vascular and pigmented lesions, scars, hair removal, facial resurfacing, wrinkle reduction, women's health treatments, tattoo removal, acne, leg veins, cellulite, and body shaping. Candela was formed in 1970 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 1 of 10
Sector: Medical Products M&A 1 of 8
Type: Add-on Acquisition M&A Deals 1 of 9
Country: Israel M&A 1 of 5
Year: 2007 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-02-20 Rakuto Bio Technologies

Yokneam, Israel

Rakuto Bio Technologies Ltd. is an Israeli-based start-up, to develop an advanced whole skin complexion whitening treatment. RBT has developed a proprietary method for skin whitening through the use of an enzyme derived from a harmless fungus. Historically, hydroquinone has been the most useful skin lightening agent, but due to significant adverse effects, hydroquinone is now banned from use in cosmetic formulations in many countries around the world.

Buy -
Mergr

Solution for

Product

Company

Legal